Expression of hypoxia-inducible factor (HIF)-1α is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma

European Journal of Cancer

Volumn 40, Issue 12, 2004, Pages 1904-1912

  Kimura, Shigeru ^a   Kitadai, Yasuhiko ^a   Tanaka, Shinji ^b   Kuwai, Toshio ^a   Hihara, Jun ^b   Yoshida, Kazuhiro ^b   Toge, Tetsuya ^b   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Hypoxia inducible factor 1 ; Oesophageal squamous cell carcinoma; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL LINE; CELL NUCLEUS; CORRELATION ANALYSIS; CYTOPLASM; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HYPOXIA; IMMUNOREACTIVITY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3843107242     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.04.035     Document Type: Article

References (36)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res. 46:1986;467-473
2. Folkman J. What is the evidence that tumors are angiogenesis-dependent. J. Natl. Cancer Inst. 82:1990;4-6
3. Wenger R.H., Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. J. Biol. Chem. 378:1997;609-616
4. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 294:2001;1337-1340
5. Takahashi Y., Kitadai Y., Bucana C.D., Clearly K.R., Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res. 55:1995;3964-3968
6. Kitadai Y., Haruma K., Tokutomi T., et al. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin. Cancer Res. 4:1998;2195-2200
7. Ryan H.E., Poloni M., McNulty W., et al. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res. 60:2000;4010-4015
8. Saleh M., Stacker S.A., Wilks A.F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res. 56:1996;393-401
9. 2 homeostasis by hypoxia-inducible factor 1α Genes Dev. 12:1998;149-162
10. 2 tension. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514
11. Crews S.T. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev. 12:1998;607-620
12. Tian H., Hammer R.E., Matsumoto A.M., Russell D.W., McKnight S.L. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12:1998;3320-3324
13. Semenza G.L. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J. Clin. Invest. 106:2000;809-812
14. Maxwell P.H., Wiesener M., Chang G.W., et al. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275
15. Semenza G.L. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64:2002;993-998
16. 2 homeostasis by hypoxia-inducible factor 1. Ann. Rev. Cell Dev. Biol. 15:1999;551-578
17. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia-inducible factor (HIF1a and HIF2a), angiogenesis and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 53:2002;1192-1202
18. Kung A.L., Wang S., Klco J.M., Kaelin W.G., Livingston D.M. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6:2000;1335-1340
19. Carmeliet P., Dor Y., Herbert J.M., et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature. 394:1998;435-439
20. Sobin LH, Wittekind C. TNM classification of malignant tumors. 5th ed. New York, Wiley, 1997
21. Koura A.N., Liu W., Kitadai Y., Singh R.K., Radinsky R., Ellis L.M. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. Cancer Res. 56:1996;3891-3894
22. Sambrook I, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989
23. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. New Engl. J. Med. 324:1991;1-8
24. Leung D.W., Cachianes G., Kuang W.J., Goeddele D.V., Ferrara N. Vascular endothelial growth factor is secreted angiogenic mitogen. Science. 246:1989;1306-1309
25. Kuwai T., Kitadai Y., Tanaka S., et al. Expression of hypoxia-inducible factor-1α is associated with tumor vascularization in human colorectal carcinoma. Int. J. Cancer. 105:2003;176-181
26. Forsythe J.A., Jiang B.H., Iyer N.V., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16:1996;4604-4613
27. Liu L.X., Lu H., Luo Y., et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 291:2002;908-914
28. Zhong H., De Marzo A.M., Laughner E., et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 59:1999;5830-5835
29. Inoue K., Ozeki Y., Suganuma T., Sugiura Y., Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Cancer. 79:1997;206-213
30. Birner P., Schindl M., Obermair A., Plank C., Breitenecker G., Oberhuber G. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 60:2000;4693-4696
31. Beasley N.J., Leek R., Alam M., et al. Hypoxia-inducible factors HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res. 62:2002;2493-2497
32. Sowter H.M., Ratcliffe P.J., Watson P., Greenberg A.H., Harris A.L. HIF-1 dependent regulation of hypoxic induction of cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61:2001;6669-6673
33. Piret J.P., Mottet D., Raes M., Michiels C. Is HIF-1α a pro- or an anti-apoptotic protein. Biochem. Pharm. 64:2002;889-892
34. Gorski D.H., Beckett M.A., Jaskowiak N.T., et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 59:1999;3374-3378
35. Goto E., Okamoto E., Adachi H., Fukuda Y., Ito H. Paradoxical effects by preoperative oral low-dose tegafur administration in human gastric carcinomas: enhanced apoptosis and increased intratumoral microvessel density. Oncol. Rep. 9:2002;1021-1026
36. Ueda M., Ueki K., Kumagai K., et al. Apoptosis and tumor angiogenesis in cervical cancer after preoperative chemotherapy. Cancer Res. 58:1998;2343-2346